Lixte Biotechnology Holdings, I

Q2 2024 13F Holders

Symbol
NMAD
CUSIP
539319301
Type
Equity
Class
COM
Num filings
7
Total reported value, excl. options
$424 k
Manager Report Date Value ($000) Shares Option Type